Skip to main content

The association between triglyceride glucose index and depression: data from NHANES 2005–2018



The association between triglyceride glucose (TyG) index and depression is unclear. We conducted this analysis to explore whether higher TyG index is associated with a higher odd of depression.


This was an observational study using data from the National Health and Nutrition Examination Survey (2005–2018), a cross-sectional and nationally representative database. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). TyG index was calculated based on the equation as follows: ln [triglyceride (mg/dL) × fasting blood glucose (mg/dL)/2], and participants were divided into quartiles based on TyG index. Weighted multivariable logistic regression models were used to explore the relationship between the TyG index and depression.


A total of 13,350 patients were included, involving 1001 (7.50%) individuals with depression. Higher TyG index is significantly associated with elevated depressive symptoms in U.S. adults. Multivariate-adjusted HRs for patients in the TyG index 4th quartile were higher for depression (OR = 1.46; 95% confidence interval (CI) 1.30, 1.64) compared with the 1st quartile of TyG index. Similar results were seen in men and women, across age groups, and baseline comorbidities.


In this large cross-sectional study, our result suggests that population with higher TyG index are significantly more likely to have depressive symptoms in U.S. adults.

Peer Review reports


Depression is a common mental health issue, clinically characterized by significant and persistent low mood symptoms, linked with considerably diminished role-functioning and quality of life, and with high risk of medical comorbidity and mortality [1]. Nearly 17.3 million adults had experienced at least one major depression in the USA in 2017. The prevalence was about 7.1%, and highest among adults reporting two or more races [2]. According to the Depression and Other Common Mental Disorders: Global Health Estimates published by WHO in 2017, there were 322 million people living with depression in the world. Meanwhile, the prevalence of depression was estimated above 7.5% among females aged 55–74 years [3]. A study on the incidence of depression in the United States showed a high prevalence of depression, and misperception of depression existing among the US adult population [4]. A substantial number of researches have shown strong relationships between depression and physical health, including Parkinson’s disease, metabolic disease, diabetes, dementia and cancer [3, 5,6,7,8,9].

Insulin resistance is an obvious feature of type 2 diabetes, hypertension, lipid metabolism disorders and even cardiovascular disease, which means decreased responsiveness to insulin. Some large population of observational studies found that diabetes was related to depression caused by insulin resistance [10,11,12]. The triglyceride-glucose (TyG) index is a new indicator of insulin resistance in recent years. Studies show that TyG index is related to disease prognosis, cardiovascular disease, dementia [12, 13]. However, the association between triglyceride glucose (TyG) index and depression is still unclear. Therefore, the purpose of this study is to explore the relationship between TyG index and depression in a large, nationally-representative sample of adults living in the United States. The dataset from the National Health and Nutrition Examination Survey (NHANES) was collected from 2005 to 2018.

Material and methods

Subjects and study design

This is a cross-sectional study, the data comes from the National Health and Nutrition Examination Survey (2005–2018). The examination components consist of medical, dental, and physiological measurements, and laboratory tests supervised by trained medical personnel. Furthermore, the adoption of various modern equipment enables the NHANES to collect reliable, high-quality data. Moreover, compensation and a report of medical findings are given to each participant, which increases the compliance of participants [2]. The total sample size of adults from the 2005–2018 assessments is 13,350. Additional details of the study design, sampling, and exclusion criteria are described in Fig. 1. Only publicly available data is used in the analysis, and the protocol of NHANES is approved by the National Center for Health Statistics (NCHS) Research Ethics Review Board.

Fig. 1

Flow chart of subject selection

Data collection and definitions

Based on the existing literature [2, 14], variables that might potentially confound between TyG index and depression symptoms are assessed: sex, age, race/ethnicity, education level. The Poverty Income Ratio (PIR) is used as a proxy measure for socioeconomic status (SES). Smoking status is categorized into never smoker (reference group), former smoker, and current smoker. Drinking status is divided into none (reference group), light, moderate, and heavy alcohol consumption, respectively according to the daily drinking volume (0, < 1, 1–< 8, and > 8 drinks per week). Body Mass Index (BMI) was divided to three groups: normal < 25.0, overweight 25.0–29.9, obese 30.0+. Congestive heart failure, coronary heart disease, cancer or malignancy, liver condition diabetes (Doctor informed you had any condition yes vs no).

TyG index is calculated by the following formula: TyG = Ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2] [13]. The depressive state was assessed using the Patient Health Questionnaire (PHQ-9) in NHANES and When PHQ-9 score ≥ 10, the interviewee is considered to have depression.

Statistical analysis

The presentation of continuous variables was divided according to their distribution status. Weighted means (standard error) were calculated for continuous variables, and weighted frequency percentages were calculated for categorical variables [15]. Chi-squared test or Kruskal-Wallis H test was employed to different TyG index quartile groups. Any non-linear relationships between TyG index levels and depression were assessed using restricted cubic spline curves. The association between TyG index levels and depression was evaluated by logistic analysis. Logistic regression models were used to calculate the odds ratio (OR) to estimate the association between TyG index levels and depression.

These covariates were chosen according to their relationship with the outcomes of interest or > 10% effect estimate changes [16]. We constructed three models; Non-adjusted model; Model 1 adjust for: Age (years); Sex; Race; Model 2 adjust for: Age (years); Race; Sex; Education level; Household income; BMI status; Drinking status; Smoking status; congestive heart failure; coronary heart disease; liver condition; cancer or malignancy; Diabetes; HDL cholesterol (mg/dL).

Stratified analyses by subgroup variables were presented with a fully adjusted Model 2. Log-likelihood ratio test was used to assess the interaction effects between TyG index and subgroup variables.

Weighted analyses were applied to account for the complex sampling design of NHANES. The detail was in this website as followed:

All analyses were performed with the statistical software EmpowerStats ( and R version 3.6.1 ( a two-side p-value of < 0.05 was considered statistically significant in all analyses.


Baseline characteristics of study participants based on the TyG index

Figure 1 described the study design, sampling, and exclusion; and 23,131 participants were excluded because of missing data on any of the covariates (missing data on Depression; TyG index, smoking status, drinking status). Our final sample included 13,350 NHANES participants, with 48.50% females and 70.50% non-Hispanic White. There were 1001 (7.50%) individuals with depression. Baseline characteristics of study participants based on the TyG index quartiles are shown in Table 1. Among all participants, the TyG index across quartiles was positively associated with age, BMI, current smoking, alcohol consumption, household income high prevalence of diabetes, congestive heart failure, coronary heart disease, liver condition, cancer or malignancy (all p < 0.001). In addition, regular HDL cholesterol was negatively associated with the TyG index across quartiles (all p < 0.001).

Table 1 Weighted baseline characteristics according to triglyceride-glucose index quartile

Associations between TyG index and depression

As shown in Fig. 2, Generalized Additive Models suggested that the relationship between TyG index and depression was linear. In Table 2, after adjusting for demographic characteristics, higher TyG index was associated with higher relative risks of depression. Compared to the 1st quartile of TyG index, multivariate-adjusted OR for patients in the TyG index 4th quartile had higher odds of having depression (OR = 1.46; 95% confidence interval (CI) 1.30, 1.64). Adults with diabetes, congestive heart failure, coronary heart disease, liver condition, cancer or malignancy were more likely to suffer from depression.

Fig. 2

Restricted cubic spline fitting for the association between TyG index levels with depression

Table 2 Weighted relationship between Triglyceride-glucose index and depression

Subgroup analyses was performed to evaluate the robustness of the association between TyG index and depression. In the adjusted model 2, the results of stratified analysis showed that the association of TyG index was similar in the most of the sub-populations (Details in Fig. 3 and Table S1). The results of univariate analysis of depression were shown in Table S2, and the relationship between Triglyceride, glucose and depression was shown in Table S3.

Fig. 3

Odds of depression subgroups based on the increasing TyG index with various clinical variables


In this national representative cross-sectional study, the association between TyG index and depression was assessed. The main finding of this article is that a high level of TyG was associated with a higher odds of having depression in the US adult population. The result is still consistent after different stratification analysis and sensitivity analysis. To our best knowledge, this is the first study to explore the association between the TyG index and depression in the general population.

The details of the mechanism explaining the relationship between the TyG index and depression still need to be further explored, and there may be several possible explanations as follows. Firstly, patients with depression have adverse insulin resistance (IR). A cross-sectional study involving more than 160,000 people in South Korea showed that higher risk of depression was associated with insulin resistance. As insulin resistance increases, the risk of depression in young adults and non-diabetic individuals increases by 4 and 17% respectively [17]. TyG index is another new indicator used to evaluate insulin resistance status in recent years. This present study was the first in which a positive association was observed between TyG index quartile and depression in a large population. The results of this study are similar to those previously published, based on HOMAIR index, an indicator of insulin resistance, in a large population. Meanwhile, the relationship between TyG and the depression is still consistent even in various subgroup analysis.

Secondly, Reverse causality may also explain the relationship between high level of TyG and higher odds of depression. Higher TyG index not only indicates insulin resistance, but also indicates adverse health conditions, associated with cerebrovascular disease, cardiovascular disease, obesity, diabetes, hypertension, metabolic syndrome, lipid metabolism disorders [18,19,20]. The disease state may also cause an increase in levels of triglycerides and blood sugar. The results of this study show that comorbidities are more frequent in individuals with the high levels of TyG index. Also, high levels of triglyceride are an indirect marker of severe disease. The association between high levels of TyG index and higher odds of having depression is the strongest in age, sex and race adjusted model, and is reduced when it is adjusted for baseline comorbidities. After excluding individuals known diabetes, congestive heart failure, coronary heart disease, liver condition, cancer or malignancy at baseline, the association remains after this adjustment.

Thirdly, inflammatory and oxidative stress may play an important role in the association of TyG index with depression. Previous observational studies have shown positive associations of TyG index with inflammatory indicators of white blood cells and C-reactive protein, and high TyG index is related to endothelial dysfunction, inflammation response, and oxidative stress [21]. Inflammation can damage vascular endothelium, meanwhile, oxidative stress also causes vascular endothelial damage, involving the occurrence and progression of a variety of diseases, such as vascular depression and dementia [22].

Our results play a very important role in further understanding the relationship between insulin resistance and depression, especially in the general population. Patient with insulin resistance are generally accompanied by disorders of blood glucose or lipid metabolism [21]. Blood lipids further induce insulin resistance. The possible explanation is glucose fatty acid cycle hypothesis [23, 24]. When compared to healthy controls, depressive individuals are found with higher triglycerides and lower HDL-cholesterol levels. A study by Jae-Hon Lee et al. found that triglycerides were likely causal risk factors for depression. The odds of being depression increased by 18% for per standard deviation increase in genetically-predicted triglycerides. Therefore, the occurrence of depression can be reduced by controlling triglyceride levels [25]. Compared with the HOMA-IR indicator, TyG index is a better indicator of arterial stiffness. TyG index can serve as a practical alternative of IR measurement [26]. Previous evidence indicates that depression has a certain correlation with dementia and Alzheimer’s disease (AD), and clarifies the risk factors of depression which will help to further reduce dementia and AD [27]. A large cohort study found that TyG index is a risk factor for dementia, independent of traditional cardiovascular risk factors [14]. TyG is both related to depression and dementia, and we need to further explore the common mechanism between them to help block the cross-influence in depression and dementia. Greater knowledge of the physiologic may open avenues for specific therapies of AD.

In this study, we did a comparison between those who had been included vs those who not (Detail in table s4 and s5). The results showed that there was no difference between the two groups only in “depression, drinking status, cancer or malignancy, congestive heart failure, and coronary heart disease”. We admitted that it might have selection bias, but we established three models by adjusting different variables. The direction of the models is consistent. Although there are certain flaws in sample selection, our conclusions are still reliable. This study provides a basis for future multi-center cohort studies on depression and TyG.

The present study equally experiences several limitations. Firstly, due to the cross-sectional nature, this study does not imply causality. The finding may not be directly extrapolated to ethnic groups and other regions. The result is mainly applicable in the United States. Secondly, only one-time participants self-report whether they have experienced depressive symptoms using the PHQ-9 at least for 2 weeks in the previous year. Moreover, depression symptoms include mild and severe, which may differ in their relations with TyG index. Furthermore, data on medications is not included which might affect depression as well as influence on lipid and glucose metabolism disorders. Finally, the design of the study is observational, and we cannot draw conclusions about the question of causality.


High TyG index is associated with a higher odds of having depression in individuals in the general population, after adjustment for case complexity. This finding indicated that the TyG index may be an independent but minor predictor of depression development.

Availability of data and materials

Raw data supporting the obtained results are available at the corresponding author.


  1. 1.

    Park LT, Zarate CA Jr. Depression in the primary care setting. N Engl J Med. 2019;380(6):559–68.

    Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Wang K, Zhao Y, Nie J, Xu H, Yu C, Wang S. Higher HEI-2015 Score Is Associated with reduced risk of depression: result from NHANES 2005-2016. Nutrients. 2021;13(2):348.

  3. 3.

    Carney RM, Freedland KE. Depression and coronary heart disease. Nat Rev Cardiol. 2017;14(3):145–55.

    Article  PubMed  Google Scholar 

  4. 4.

    Cao C, Hu L, Xu T, Liu Q, Koyanagi A, Yang L, et al. Prevalence, correlates and misperception of depression symptoms in the United States, NHANES 2015-2018. J Affect Disord. 2020;269:51–7.

    Article  PubMed  Google Scholar 

  5. 5.

    Wang S, Mao S, Xiang D, Fang C. Association between depression and the subsequent risk of Parkinson's disease: a meta-analysis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;86:186–92.

    Article  Google Scholar 

  6. 6.

    Hidese S, Asano S, Saito K, Sasayama D, Kunugi H. Association of depression with body mass index classification, metabolic disease, and lifestyle: a web-based survey involving 11,876 Japanese people. J Psychiatr Res. 2018;102:23–8.

    Article  PubMed  Google Scholar 

  7. 7.

    Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7(6):323–31.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53(12):2480–6.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Wakefield CE, Butow PN, Aaronson NA, Hack TF, Hulbert-Williams NJ, Jacobsen PB. Patient-reported depression measures in cancer: a meta-review. Lancet Psychiatry. 2015;2(7):635–47.

    Article  PubMed  Google Scholar 

  10. 10.

    Chatterjee S, Peters SA, Woodward M, Mejia Arango S, Batty GD, Beckett N, et al. Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care. 2016;39(2):300–7.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Gudala K, Bansal D, Schifano F, Bhansali A. Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig. 2013;4(6):640–50.

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Strachan MW, Reynolds RM, Frier BM, Mitchell RJ, Price JF. The relationship between type 2 diabetes and dementia. Br Med Bull. 2008;88(1):131–46.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Liu XC, He GD, Lo K, Huang YQ, Feng YQ. The triglyceride-glucose index, an insulin resistance marker, was non-linear associated with all-cause and cardiovascular mortality in the general population. Front Cardiovasc Med. 2020;7:628109.

    CAS  Article  Google Scholar 

  14. 14.

    Hong S, Han K, Park CY. The insulin resistance by triglyceride glucose index and risk for dementia: population-based study. Alzheimers Res Ther. 2021;13(1):9.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Cao C, Liu Q, Yang L, Zheng X, Lan P, Koyanagi A, et al. Handgrip strength is associated with suicidal thoughts in men: cross-sectional analyses from NHANES. Scand J Med Sci Sports. 2020;30(1):92–9.

    Article  PubMed  Google Scholar 

  16. 16.

    Jaddoe VWV, de Jonge LL, Hofman A, Franco OH, Steegers EAP, Gaillard R. First trimester fetal growth restriction and cardiovascular risk factors in school age children: population based cohort study. BMJ (Clinical research ed). 2014;348:g14.

    Google Scholar 

  17. 17.

    Lee JH, Park SK, Ryoo JH, Oh CM, Mansur RB, Alfonsi JE, et al. The association between insulin resistance and depression in the Korean general population. J Affect Disord. 2017;208:553–9.

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Zhang M, Wang B, Liu Y, Sun X, Luo X, Wang C, et al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: the rural Chinese cohort study. Cardiovasc Diabetol. 2017;16(1):30.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Zhu B, Wang J, Chen K, Yan W, Wang A, Wang W, et al. A high triglyceride glucose index is more closely associated with hypertension than lipid or glycemic parameters in elderly individuals: a cross-sectional survey from the reaction study. Cardiovasc Diabetol. 2020;19(1):112.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575–85.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Nam KW, Kwon HM, Jeong HY, Park JH, Kwon H, Jeong SM. High triglyceride-glucose index is associated with subclinical cerebral small vessel disease in a healthy population: a cross-sectional study. Cardiovasc Diabetol. 2020;19(1):53.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Luca M, Luca A. Oxidative stress-related endothelial damage in vascular depression and vascular cognitive impairment: beneficial effects of aerobic physical exercise. Oxidative Med Cell Longev. 2019;2019:8067045.

    Google Scholar 

  23. 23.

    Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1(7285):785–9.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Vasques AC, Novaes FS, de Oliveira MS, Souza JR, Yamanaka A, Pareja JC, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–e100.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Khandaker GM, Zuber V, Rees JMB, Carvalho L, Mason AM, Foley CN, et al. Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort. Mol Psychiatry. 2020;25(7):1477–86.

    Article  PubMed  Google Scholar 

  26. 26.

    Lee SB, Ahn CW, Lee BK, Kang S, Nam JS, You JH, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 2018;17(1):41.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Chan YE, Chen MH, Tsai SJ, Bai YM, Tsai CF, Cheng CM, et al. Treatment-resistant depression enhances risks of dementia and alzheimer's disease: a nationwide longitudinal study. J Affect Disord. 2020;274:806–12.

    Article  PubMed  Google Scholar 

Download references




This work was supported by a grant from Research Incubation Project of the First Affiliated Hospital of Wenzhou Medical University (Grant NO. FHY2019048, WZ).

Author information




SZ. Q and YY. S designed the study. YY. S and R.Z and participated in data collection and analysis. SZ. Q and JJ.C developed clinical protocols. R.Z drafted the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Song-Zan Qian.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

Weighted stratification analysis of Triglyceride-glucose index with depression. Table S2. Weighted univariate analysis of depression. Table S3. Relationship between Triglyceride, glucose and depression. Table S4. Baseline characteristics between Exclude and Include individual. Table S5. Missing of variables.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Shi, YY., Zheng, R., Cai, JJ. et al. The association between triglyceride glucose index and depression: data from NHANES 2005–2018. BMC Psychiatry 21, 267 (2021).

Download citation


  • Depression
  • Depressive symptoms
  • Triglyceride glucose index
  • Insulin resistance